MLTX Earnings Date: Nov 4, 2026 (Estimated) — MoonLake Immunotherapeutics
NASDAQ · Healthcare · Biotechnology
Updated
When is MLTX's next earnings date?
MoonLake Immunotherapeutics (MLTX) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.77.
How did MLTX do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), MoonLake Immunotherapeutics posted EPS of -$0.84 versus the -$0.91 estimate, a beat of 6.7%. Revenue was $0. The stock's 1-day post-earnings move was -5.1%.
How much does MLTX stock move after earnings?
MLTX beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.5% (up or down) in the day after earnings.
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.91 | -0.84 | +6.67% | $0 | ✅ Beat | -5.09% | -9.80% | -18.18% |
| 2026-05-11 | Q1 2026 | -0.90 | -0.98 | -8.89% | $0 | ❌ Miss | +10.43% | +2.87% | +4.34% |
| 2026-02-25 | Q4 2025 | -0.99 | -0.92 | +7.07% | $0 | ✅ Beat | +0.11% | -2.80% | -0.99% |
| 2025-11-05 | Q3 2025 | -0.91 | -1.10 | -20.88% | $0 | ❌ Miss | +4.54% | +15.99% | +48.03% |
| 2025-08-05 | Q2 2025 | -0.75 | -0.87 | -16.00% | $0 | ❌ Miss | +0.17% | +0.11% | +11.59% |
| 2025-02-26 | Q4 2024 | -0.62 | -0.72 | -16.13% | $0 | ❌ Miss | +4.03% | -1.06% | -5.75% |
| 2024-11-07 | Q3 2024 | -0.44 | -0.56 | -27.27% | $0 | ❌ Miss | -1.57% | -0.82% | +5.50% |
| 2024-08-07 | Q2 2024 | -0.28 | -0.39 | -39.29% | $0 | ❌ Miss | -1.98% | +3.16% | +3.76% |
Showing last 8 quarters.